Digital Content 
NEWS #PharmaBuzz
12 Dec 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/trevi-therapeutics-announces-positive-outcome-from-sample-size-re-estimation-resulting-in-no-change-to-the-current-sample-size-for-the-phase-2b-coral-trial-in-idiopathic-pulmonary-fibrosis-patients-with-chronic-cough-302329735.html
03 Dec 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/trevi-therapeutics-announces-positive-topline-results-from-human-abuse-potential-study-of-oral-nalbuphine-302321577.html
21 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/trevi-therapeutics-completes-enrollment-for-phase-2a-river-trial-in-refractory-chronic-cough-302281016.html
26 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/trevi-therapeutics-announces-additional-analyses-of-cough-relief-time-from-ph2a-canal-trial-accepted-for-oral-presentation-at-chest-2024-302259142.html
19 Sep 2024
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216050
28 Aug 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/trevi-therapeutics-to-participate-in-september-investor-and-medical-conferences-302232241.html
LOOKING FOR A SUPPLIER?
Share